Accelerating AAV process development with a PAT-driven TFF system

DOI: 10.18609/cgti.2024.148

Cell & Gene Therapy Insights 2024; 10(9), 1303

Published: 31 October
Webinar Digest
Teva Smith


Ultrafiltration/diafiltration (UF/DF) represents a crucial step in bioprocessing, but traditional methods can pose a range of challenges. This poster describes streamlined process development with a system uniquely controlled by real-time titer measurement acquired through in-line variable pathlength spectroscopy.

AAV case study data demonstrates automated process control, exhibiting the system’s efficacy across various final endpoints.